Strategy

Dec 11, 2014
Pharmaceutical Executive
AmerisourceBergen exemplifies the shift underway among pharma's supply chain drivers, best summarized as "follow the customer". Company veteran Peyton Howell tells us more.
Dec 10, 2014
Pharmaceutical Executive
Rebecca Ashkenazy, Alex Chang, Cyndi Green, Ted Miller, and Christine de los Reyes discuss how the 3S framework - science, synergy, and survival -- can build more value in biopharmaceutical dealmaking.
Nov 01, 2014
Pharmaceutical Executive
Jesper Hoiland, Novo Nordisk's President for North America, assesses the challenges and opportunities during his first year at the helm of the diabetes franchise leader's biggest affiliate market.
May 15, 2014
Pharmaceutical Executive
By Pharmaceutical Executive Editors
MNCs can learn a lot from generic companies in their strategic approaches to emerging markets.
Apr 16, 2014
Pharmaceutical Executive
By Pharmaceutical Executive Editors
California's Bay Area and the Boston/Cambridge nexus continue to dominate bioinnovation in the US. Pharm Exec looks at the factors contributing to the strategic dominance of these regions.
Mar 03, 2014
Pharmaceutical Executive
Profitability now depends on metrics to help companies answer a key strategic question: "stay the course" with more investment in sales and marketing? Or "stand down" and deploy those scarce assets somewhere else?
Feb 01, 2014
Pharmaceutical Executive
Millennium Takeda's new president, Anna Protopapas, explains the life choices that brought her from Cyprus to Cambridge—and a lead position in the hotly contested search to make cancer a treatable disease.
Jan 21, 2014
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Successful innovation now has to align with key metrics of value—can an old baseball metaphor help guide the way?
Jan 21, 2014
Pharmaceutical Executive
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. It is time to be decisive — muddling through is so yesterday.
Nov 25, 2013
Pharmaceutical Executive
Pharm Exec convenes a diverse panel of experts to identify the key markers of common ground: its time, people, and money against that greatest intangible—hope.
native1_300x100
lorem ipsum